Invisioner, We, as investors and potential pati
Post# of 148179
(Total Views: 684)
Posted On: 09/28/2020 4:48:50 PM
Re: invisioner #58261
Invisioner,
We, as investors and potential patients, are lucky for the impending impact of leronlimab.
My feeling is that the role that inflammation plays in many, if not most chronic disease, is still under appreciated in the medical community.
It really upends a lot of medicine. As Carl Sagan noted, “ Extraordinary claims require extraordinary evidence.”
The evidence, IMO, is undeniable despite its slow acknowledgment and acceptance.
We’re getting there.
We, as investors and potential patients, are lucky for the impending impact of leronlimab.
My feeling is that the role that inflammation plays in many, if not most chronic disease, is still under appreciated in the medical community.
It really upends a lot of medicine. As Carl Sagan noted, “ Extraordinary claims require extraordinary evidence.”
The evidence, IMO, is undeniable despite its slow acknowledgment and acceptance.
We’re getting there.
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼